Drug Database
Back to search

Poland· PL-100030506

Differin

A adapalene product containing adapalenum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC D10AD03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDifferinATCD10AD03REGISTER NO.PL-100030506PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about adapalenumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Adapalene is registered in 16 of 19 countries.

Countries holding a registration under ATC D10AD03 (adapalene), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search adapalene products by name

Adapalene · ATC D10AD03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Adapalenum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
D10AD03
ATC class
Adapalene
Defined daily dose
1 mg, T
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909997010687

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for adapalene.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check adapalene against other medicinesHow interaction checks work

Adapalene · interactions on record

80 records

  • 1 severe
  • 8 moderate
  • 71 info

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • Salicylic acidD01AE12moderate
  • IsotretinoinD10AD04moderate
  • Benzoyl peroxideD10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Adapalene in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All adapalene products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Differin
  • Belgium · Differin
  • Cyprus · Adaferin
  • Czechia · Belakne, Differine
  • Germany · Differin, Dipalen
  • Denmark · Redap
  • Estonia · Differin
  • Spain · Differine
  • Finland · Differin
  • France · Adapalene Teva, Adapalene Zentiva
  • United Kingdom (Northern Ireland) · Differin
  • Greece · Adaferin
  • Croatia · Sona
  • Hungary · Differin
  • Ireland · Differin
  • Iceland · Differin
  • Italy · Differin
  • Lithuania · Differin
  • Luxembourg · Differin
  • Latvia · Differin
  • Malta · Differin
  • Netherlands · Differin
  • Norway · Differin
  • Portugal · Differin
  • Sweden · Differin
  • Slovenia · Belakne
  • Slovakia · Belakne, Differine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/caa4a7e2-7e44-4700-805d-25b2d4229d97
GET /v1/drugs/caa4a7e2-7e44-4700-805d-25b2d4229d97?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Żel",
  "source": "urpl",
  "strength": "1 mg/g",
  "packaging": "05909997010687 ¦ Rp ¦ 801\n1 tuba 30 g",
  "substance": null,
  "common_name": "Adapalenum",
  "pl_product_id": "100030506",
  "pozwolenie_nr": "13/09",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-03-18"
}
API referenceMCP serverPlans

See everything about adapalene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console